Patients The strategic opportunity: Owning the behaviour layer Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.
Patients Physical performance × nutrition — a multiplicative relation... Physical performance and nutrition are not just complementary, but biologically multiplicative.
Patients Longevity as the new health paradigm: The control system Nutrition shapes the biology of ageing; lifestyle determines how that biology is expressed
R&D Longevity studies in life sciences today Longevity has been discussed for a while now in the context of life sciences and pharma - we take a look at what's new now with Anat Naschitz.
Patients Why biohackers are ditching vague health metrics Precision diagnostics enable targeted therapeutics.
R&D Why everyone should care about longevity, with Boyang Wang In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Boyang Wang, the founder of Immortal Dragons.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.